Subject: Growth Hormone (GH) Therapy*. Effective Date: July 29, 2003. Department(s): Utilization Management. Policy: Treatment with GH (HCPCS J2941) is reimbursable under Plans. administered by QualCare, Inc. for the indications listed below. Objective: To provide proper and consistent reimbursement for and to ensure.
Branch and is intended to preserve the role of CRS as a confidential resource. decision whether and how to place individual CRS products in the public domain. congressional publications, or through their own web sites. CRS for individual congressional clients, should be maintained. interpreted broadly.
Anything you tell us is confidential. Nothing you say will be personally attributed to you in any reports that result from this focus group. All of our reports will be written in a manner that no individual comment can be attributed to a particular person. Your participation in this focus group is totally voluntary.